Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.

< BACK TO ARCHIVE


2021 Jan 11


Vaccine


http://www.ncbi.nlm.nih.gov/pubmed/33441234?dopt=Abstract

Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.

Authors

Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.
Ackerson B, Qian L, Sy LS, Bruxvoort K, Wu J, Luo Y, Diaz-Decaro J, Talarico C, Tseng H F
Vaccine. 2021 Jan 11.
PMID: 33441234.

Abstract

In 2017, a new adjuvanted recombinant zoster vaccine (RZV) was recommended for adults ≥50 years as two-dose series 2-6 months apart. We evaluated two-dose RZV completion and factors associated with completion.
Read This Paper